Monitoring of hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladder cancer by optical spectroscopy.

Monitoring of the tissue response to photodynamic therapy (PDT) can provide important information to help optimize treatment variables such as drug and light dose, and possibly predict treatment outcome. A urinary bladder cancer cell line (AY-27) was used to induce orthotopic transitional cell carcinomas (TCC) in female Fischer rats, and hexyl 5-aminolevulinate (HAL, 8 mM, 1 h)-induced PDT was performed on day 14 after instillation of the cancer cells (20 J/cm(2) fluence at 635 nm). In vivo optical reflectance and fluorescence spectra were recorded from bladders before and after laser treatment with a fiberoptic probe. Calculated fluorescence bleaching and oxygen saturation in the bladder wall were examined and correlated to histology results. Reflectance spectra were analyzed using a three-layer optical photon transport model. Animals with TCC treated with PDT showed a clear treatment response; decreased tissue oxygenation and protoporphyrin IX (PpIX) fluorescence photobleaching were observed. Histology demonstrated that 3 of 6 animals with treatment had no sign of the tumor 7 days after PDT treatment. The other 3 animals had significantly reduced the tumor size. The most treatment-responsive animals had the highest PpIX fluorescence prior to light irradiation. Thus, optical spectroscopy can provide useful information for PDT. The model has proved to be very suitable for bladder cancer studies.

[1]  John Tulip,et al.  Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers. , 2003, The Journal of urology.

[2]  Wiley Interscience,et al.  Methemoglobin formation during laser induced photothermolysis of vascular skin lesions , 2004, Lasers in surgery and medicine.

[3]  S. Rockwell,et al.  Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.

[4]  Tobias Kiesslich,et al.  The Modes of Cell Death Induced by PDT: An Overview , 2003 .

[5]  Manfred Kunz,et al.  Molecular responses to hypoxia in tumor cells , 2003, Molecular Cancer.

[6]  Kristian Berg,et al.  Photobleaching of protoporphyrin IX in cells incubated with 5‐aminolevulinic acid , 1997, International journal of cancer.

[7]  Louis B Harrison,et al.  Impact of tumor hypoxia and anemia on radiation therapy outcomes. , 2002, The oncologist.

[8]  A. Leroux,et al.  Kinetics, biodistribution and therapeutic efficacy of hexylester 5-aminolevulinate induced photodynamic therapy in an orthotopic rat bladder tumor model. , 2004, The Journal of urology.

[9]  H. H. Pennes.  Analysis of tissue and arterial blood temperatures in the resting human forearm. , 1948, Journal of applied physiology.

[10]  L. Guillou,et al.  Fluorescence Photodetection (pd) and Photodynamic Therapy Photodetection of Early Human Bladder Cancer Based on the Fluorescence of 5-aminolaevulinic Acid Hexylester- Induced Protoporphyrin Ix: a Pilot Study , 2022 .

[11]  H Anholt,et al.  Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. , 1997, Cancer research.

[12]  J Moan,et al.  Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells. , 2001, Cancer letters.

[13]  J. M. Salhany,et al.  Direct generation of superoxide anions by flash photolysis of human oxyhemoglobin. , 1977, The Journal of biological chemistry.

[14]  W. Zijlstra,et al.  Spectrophotometry of Hemoglobin: Absorption Spectra of Bovine Oxyhemoglobin, Deoxyhemoglobin, Carboxyhemoglobin, and Methemoglobin , 1997 .

[15]  L. O. Svaasand,et al.  A mathematical model for light dosimetry in photodynamic destruction of human endometrium. , 1996, Physics in medicine and biology.

[16]  Gerald G. Miller,et al.  Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model , 1999, British Journal of Cancer.

[17]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[18]  K. Berg,et al.  A comparative study of normal and reverse phase high pressure liquid chromatography for analysis of porphyrins accumulated after 5-aminolaevulinic acid treatment of colon adenocarcinoma cells. , 2000, Cancer letters.

[19]  W. Star,et al.  In situ light dosimetry during whole bladder wall photodynamic therapy: clinical results and experimental verification. , 1993, Physics in medicine and biology.

[20]  A. Neuberger,et al.  The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .

[21]  Michael J. Emanuele,et al.  Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome , 2004, Cancer Research.

[22]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[23]  A. Welch,et al.  A review of the optical properties of biological tissues , 1990 .

[24]  T. Hasan,et al.  In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. , 1999, Cancer research.

[25]  Stanley B. Brown,et al.  5-Aminolaevulinic Acid Methyl Ester Transport on Amino Acid Carriers in a Human Colon Adenocarcinoma Cell Line¶ , 2001, Photochemistry and photobiology.

[26]  A. Nandi,et al.  Haemoglobin: A scavenger of superoxide radical , 1991, Journal of Biosciences.

[27]  K. Berg,et al.  Cell specific effects of polyunsaturated fatty acids on 5-aminolevulinic acid based photosensitization , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[28]  L. Guillou,et al.  Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light‐induced fluorescence of protoporphyrin IX following topical application of 5‐aminolevulinic acid: Preliminary results , 1997, Lasers in surgery and medicine.

[29]  T. Roskams,et al.  In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder , 2005, BJU international.

[30]  François Guillemin,et al.  Determination of the maximal tumor:normal bladder ratio after i.p. or bladder administration of 5-aminolevulinic acid in Fischer 344 rats by fluorescence spectroscopy in situ , 2002, Anti-cancer drugs.

[31]  J. Findlay,et al.  Eight-week toxicity study of 60 Hz magnetic fields in F344 rats and B6C3F1 mice. , 1997, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[32]  H. Grossman,et al.  A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. , 2007, The Journal of urology.

[33]  R Baumgartner,et al.  Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.

[34]  Q. Peng,et al.  5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.

[35]  H. H. Pennes.  Analysis of tissue and arterial blood temperatures in the resting human forearm. 1948. , 1948, Journal of applied physiology.

[36]  U. Nseyo,et al.  Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience. , 1998, Journal of clinical laser medicine & surgery.